Application 021479

Type
NDA
Sponsor
BAUSCH

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ZELAPARSELEGILINE HYDROCHLORIDETABLET, ORALLY DISINTEGRATING;ORAL1.25MGYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021479-001ZELAPARSELEGILINE HYDROCHLORIDE1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-1431067a03dcf5…
2025-08-23 18:47 UTC2025-08N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-146a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-1403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-142680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-145bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-1479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-141e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-148072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-145c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-145d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-144b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-1474a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-1487673890dc5c…
2021-03-12 10:30 UTC2021-03N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-145aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-148869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-143f01610625f2…
2019-09-15 20:21 UTC2019-09N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14b00525d2431f…
2019-07-19 19:46 UTC2019-07N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-146a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-141c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-149b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-143f0d92c62455…
2023-05-13 08:27 UTC2023-05N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14053a50430f4f…
2023-01-26 05:58 UTC2023-01N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-143bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-143a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N021479-001ZELAPAR1.25MGTABLET, ORALLY DISINTEGRATING / ORALRLD, RS2006-06-14e64feba35796…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZELAPARSELEGILINE HYDROCHLORIDEBausch Health US, LLC380d7717-2a79-42f3-a712-efe5e7696ba02021-06-01Warnings, Adverse reactionsExact identifier
application applno (NDA): 021479
application number: NDA021479
ndc (product): 0187-0453

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 6 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0187-0453ZELAPARSELEGILINE HYDROCHLORIDEValeant Pharmaceuticals North America LLCNDACurrent
0187-0453ZELAPARSELEGILINE HYDROCHLORIDEBausch Health US, LLCNDACurrent
0187-0453ZELAPARSELEGILINE HYDROCHLORIDEBausch Health US, LLCNDACurrent
0187-0453ZELAPARSELEGILINE HYDROCHLORIDEValeant Pharmaceuticals North America LLCNDACurrent
0187-0453ZELAPARSELEGILINE HYDROCHLORIDEValeant Pharmaceuticals North America LLCNDACurrent
0187-0453ZELAPARSELEGILINE HYDROCHLORIDEBausch Health US, LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
67838SUPPL2021-06-17
67836SUPPL2021-06-17
59753SUPPL2019-08-20
15566SUPPL2014-08-19
5497SUPPL2014-08-01
21684ORIG2009-01-15
37035SUPPL2009-01-06
27897SUPPL2009-01-06
15565SUPPL2009-01-06
5496SUPPL2009-01-06
27896ORIG2006-06-20
15564ORIG2006-06-20